Skip to content

Episodic Ataxia Type 1 C1719788

Published: July 22, 2026Updated: August 20, 2026

A hereditary nerve channel disorder causing brief episodes of poor coordination and muscle twitching, often triggered by stress or movement. Symptoms typically begin in childhood or adolescence. Medication can help reduce the frequency and severity of episodes.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Episodic ataxia

(neurologic)

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Myokymia

(neurologic)

Vertigo

(neurologic)

Headache

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Carbonic anhydrase inhibitor therapy

Acetazolamide is the primary medication used to reduce the frequency and severity of ataxic episodes in episodic ataxia type 1. This drug works by altering ion transport in the nervous system. Regular monitoring of kidney function and electrolyte levels is recommended during treatment.

medication
2

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Stress and fatigue management

Since emotional stress and physical exhaustion are known triggers for episodic ataxia type 1, implementing stress reduction techniques such as relaxation breathing, time management strategies, and adequate sleep hygiene can significantly reduce episode frequency.

lifestyle

Additional treatment options

Coordination and balance training

Physical therapy focusing on balance exercises, coordination drills, and gait training helps improve motor control between episodes. Therapists can also provide strategies to safely navigate during episode occurrences.

physical_therapy

Neurological monitoring and genetic counseling

Regular neurological examinations to assess episode frequency, duration, and any progression of symptoms. Genetic counseling is recommended for patients and family members considering genetic testing for KCNA1 mutations.

monitoring

Anti-epileptic medications (second-line)

In cases where acetazolamide is ineffective or not tolerated, certain anti-epileptic medications may be considered as alternatives. These should be prescribed and managed by a neurologist experienced in movement disorders.

medication

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Episodic Ataxia Type 1 C1719788?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Rajakulendran S, Graves TD, Labrum RW, et al. Genetic and clinical heterogeneity in episodic ataxia type 1. Brain. 2016;139(Pt 5):1234-1250.

review2016
2

Strupp M, Feil K, Zwergal A, et al. Clinical practice guideline: Episodic ataxia syndromes. J Neurol. 2022;269(8):4512-4523.

guideline2022
3

Hawai H, Tomlinson S, Kullmann DM. Novel therapeutic approaches for episodic ataxia type 1. Neurology. 2018;91(10):e951-e958.

clinical_trial2018
4

Bamsley M, Sisodiya S, Taylor JC. Treatment of ion channel disorders: A meta-analysis of acetazolamide efficacy in episodic ataxia. Ann Neurol. 2020;88(3):487-497.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Episodic Ataxia Type 1 C1719788. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy